ID   KAT8_HUMAN              Reviewed;         458 AA.
AC   Q9H7Z6; A8K4Z1; G5E9P2; Q659G0; Q7LC17; Q8IY59; Q8WYB4; Q8WZ14;
AC   Q9HAC5; Q9NR35;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 2.
DT   10-MAY-2017, entry version 149.
DE   RecName: Full=Histone acetyltransferase KAT8;
DE            EC=2.3.1.48 {ECO:0000269|PubMed:10786633, ECO:0000269|PubMed:21217699, ECO:0000269|PubMed:22020126, ECO:0000269|PubMed:22547026};
DE   AltName: Full=Lysine acetyltransferase 8;
DE   AltName: Full=MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1;
DE            Short=MYST-1;
DE            Short=hMOF;
GN   Name=KAT8; Synonyms=MOF, MYST1; ORFNames=PP7073;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-458 (ISOFORM 1).
RA   Borrow J., Housman D.E.;
RT   "Structure and function of the human MYST family: MOZ2, MYST1 and
RT   MYST2.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 29-458 (ISOFORM 1), CATALYTIC ACTIVITY,
RP   AND SUBCELLULAR LOCATION.
RC   TISSUE=Heart;
RX   PubMed=10786633; DOI=10.1016/S0167-4781(99)00211-0;
RA   Neal K.C., Pannuti A., Smith E.R., Lucchesi J.C.;
RT   "A new human member of the MYST family of histone acetyl transferases
RT   with high sequence similarity to Drosophila MOF.";
RL   Biochim. Biophys. Acta 1490:170-174(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 153-458 (ISOFORM 1).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 201-458 (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   INTERACTION WITH MORF4L1, AND FUNCTION.
RX   PubMed=12397079; DOI=10.1074/jbc.M203839200;
RA   Pardo P.S., Leung J.K., Lucchesi J.C., Pereira-Smith O.M.;
RT   "MRG15, a novel chromodomain protein, is present in two distinct
RT   multiprotein complexes involved in transcriptional activation.";
RL   J. Biol. Chem. 277:50860-50866(2002).
RN   [10]
RP   IDENTIFICATION IN THE MLL1/MLL COMPLEX.
RX   PubMed=15960975; DOI=10.1016/j.cell.2005.04.031;
RA   Dou Y., Milne T.A., Tackett A.J., Smith E.R., Fukuda A., Wysocka J.,
RA   Allis C.D., Chait B.T., Hess J.L., Roeder R.G.;
RT   "Physical association and coordinate function of the H3 K4
RT   methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.";
RL   Cell 121:873-885(2005).
RN   [11]
RP   INTERACTION WITH ATM, AND FUNCTION.
RX   PubMed=15923642; DOI=10.1128/MCB.25.12.5292-5305.2005;
RA   Gupta A., Sharma G.G., Young C.S.H., Agarwal M., Smith E.R.,
RA   Paull T.T., Lucchesi J.C., Khanna K.K., Ludwig T., Pandita T.K.;
RT   "Involvement of human MOF in ATM function.";
RL   Mol. Cell. Biol. 25:5292-5305(2005).
RN   [12]
RP   IDENTIFICATION OF MSL COMPLEX COMPONENTS, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16227571; DOI=10.1128/MCB.25.21.9175-9188.2005;
RA   Smith E.R., Cayrou C., Huang R., Lane W.S., Cote J., Lucchesi J.C.;
RT   "A human protein complex homologous to the Drosophila MSL complex is
RT   responsible for the majority of histone H4 acetylation at lysine 16.";
RL   Mol. Cell. Biol. 25:9175-9188(2005).
RN   [13]
RP   ERRATUM.
RA   Smith E.R., Cayrou C., Huang R., Lane W.S., Cote J., Lucchesi J.C.;
RL   Mol. Cell. Biol. 26:387-387(2006).
RN   [14]
RP   INTERACTION WITH KANSL1.
RX   PubMed=16543150; DOI=10.1016/j.molcel.2006.02.007;
RA   Mendjan S., Taipale M., Kind J., Holz H., Gebhardt P., Schelder M.,
RA   Vermeulen M., Buscaino A., Duncan K., Mueller J., Wilm M.,
RA   Stunnenberg H.G., Saumweber H., Akhtar A.;
RT   "Nuclear pore components are involved in the transcriptional
RT   regulation of dosage compensation in Drosophila.";
RL   Mol. Cell 21:811-823(2006).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-113, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   FUNCTION IN HISTONE H4 ACETYLATION, IDENTIFICATION IN NSL COMPLEX, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=20018852; DOI=10.1074/jbc.C109.087981;
RA   Cai Y., Jin J., Swanson S.K., Cole M.D., Choi S.H., Florens L.,
RA   Washburn M.P., Conaway J.W., Conaway R.C.;
RT   "Subunit composition and substrate specificity of a MOF-containing
RT   histone acetyltransferase distinct from the male-specific lethal (MSL)
RT   complex.";
RL   J. Biol. Chem. 285:4268-4272(2010).
RN   [18]
RP   INTERACTION WITH KANSL1.
RX   PubMed=20620954; DOI=10.1016/j.molcel.2010.05.021;
RA   Raja S.J., Charapitsa I., Conrad T., Vaquerizas J.M., Gebhardt P.,
RA   Holz H., Kadlec J., Fraterman S., Luscombe N.M., Akhtar A.;
RT   "The nonspecific lethal complex is a transcriptional regulator in
RT   Drosophila.";
RL   Mol. Cell 38:827-841(2010).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-348, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 174-449 IN COMPLEX WITH
RP   ACETYL-COA AND ZINC, AND ACETYLATION AT LYS-274.
RG   Structural genomics consortium (SGC);
RT   "MYST histone acetyltransferase 1.";
RL   Submitted (MAY-2007) to the PDB data bank.
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 174-449 IN COMPLEX WITH ZINC
RP   IONS, AND ACETYLATION AT LYS-274.
RX   PubMed=21691301; DOI=10.1038/cr.2011.105;
RA   Sun B., Guo S., Tang Q., Li C., Zeng R., Xiong Z., Zhong C., Ding J.;
RT   "Regulation of the histone acetyltransferase activity of hMOF via
RT   autoacetylation of Lys274.";
RL   Cell Res. 21:1262-1266(2011).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 174-458 IN COMPLEX WITH
RP   MSL1; ZINC ION AND ACETYL-COA, FUNCTION, CATALYTIC ACTIVITY, ACTIVE
RP   SITE, IDENTIFICATION BY MASS SPECTROMETRY, ACETYLATION AT LYS-274,
RP   INTERACTION WITH KANSL1; MSL1 AND MSL3, AND MUTAGENESIS OF LYS-274;
RP   CYS-316 AND GLU-350.
RX   PubMed=21217699; DOI=10.1038/nsmb.1960;
RA   Kadlec J., Hallacli E., Lipp M., Holz H., Sanchez-Weatherby J.,
RA   Cusack S., Akhtar A.;
RT   "Structural basis for MOF and MSL3 recruitment into the dosage
RT   compensation complex by MSL1.";
RL   Nat. Struct. Mol. Biol. 18:142-149(2011).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 170-458 IN COMPLEX WITH
RP   MSL1, ACETYLATION AT LYS-274, FUNCTION IN MSL AND NSL COMPLEX,
RP   FUNCTION, CATALYTIC ACTIVITY, AND INTERACTION WITH KANSL1; MSL1 AND
RP   MSL3.
RX   PubMed=22547026; DOI=10.1038/cr.2012.72;
RA   Huang J., Wan B., Wu L., Yang Y., Dou Y., Lei M.;
RT   "Structural insight into the regulation of MOF in the male-specific
RT   lethal complex and the non-specific lethal complex.";
RL   Cell Res. 22:1078-1081(2012).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 177-458 IN COMPLEX WITH ZINC,
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, ACETYLATION AT LYS-274,
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS OF LYS-274.
RX   PubMed=22020126; DOI=10.1038/emboj.2011.382;
RA   Yuan H., Rossetto D., Mellert H., Dang W., Srinivasan M., Johnson J.,
RA   Hodawadekar S., Ding E.C., Speicher K., Abshiru N., Perry R., Wu J.,
RA   Yang C., Zheng Y.G., Speicher D.W., Thibault P., Verreault A.,
RA   Johnson F.B., Berger S.L., Sternglanz R., McMahon S.B., Cote J.,
RA   Marmorstein R.;
RT   "MYST protein acetyltransferase activity requires active site lysine
RT   autoacetylation.";
RL   EMBO J. 31:58-70(2012).
CC   -!- FUNCTION: Histone acetyltransferase which may be involved in
CC       transcriptional activation. May influence the function of ATM. As
CC       part of the MSL complex it is involved in acetylation of
CC       nucleosomal histone H4 producing specifically H4K16ac. As part of
CC       the NSL complex it may be involved in acetylation of nucleosomal
CC       histone H4 on several lysine residues. That activity is less
CC       specific than the one of the MSL complex. Can also acetylate
CC       TP53/p53 at 'Lys-120'. {ECO:0000269|PubMed:12397079,
CC       ECO:0000269|PubMed:15923642, ECO:0000269|PubMed:20018852,
CC       ECO:0000269|PubMed:21217699, ECO:0000269|PubMed:22020126,
CC       ECO:0000269|PubMed:22547026}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-acetyl-L-lysine. {ECO:0000269|PubMed:10786633,
CC       ECO:0000269|PubMed:21217699, ECO:0000269|PubMed:22020126,
CC       ECO:0000269|PubMed:22547026}.
CC   -!- SUBUNIT: Component of a multisubunit histone acetyltransferase
CC       complex (MSL) at least composed of the MOF/KAT8, MSL1/hampin,
CC       MSL2L1 and MSL3L1. Interacts with MSL1; the interaction is direct.
CC       Component of the NSL complex at least composed of MOF/KAT8,
CC       KANSL1, KANSL2, KANSL3, MCRS1, PHF20, OGT1/OGT, WDR5 and HCFC1.
CC       Interacts with KANSL1; the interaction is direct. Component of
CC       some MLL1/MLL complex, at least composed of the core components
CC       KMT2A/MLL1, ASH2L, HCFC1, WDR5 and RBBP5, as well as the
CC       facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1,
CC       LAS1L, MAX, MCRS1, MGA, MOF/KAT8, PELP1, PHF20, PRP31, RING2,
CC       RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9
CC       and TEX10. Interacts with the chromodomain of MORF4L1/MRG15.
CC       Interacts with ATM through the chromodomain. Interacts with
CC       KANSL1; the interaction is direct. {ECO:0000269|PubMed:12397079,
CC       ECO:0000269|PubMed:15923642, ECO:0000269|PubMed:15960975,
CC       ECO:0000269|PubMed:16543150, ECO:0000269|PubMed:20018852,
CC       ECO:0000269|PubMed:20620954, ECO:0000269|PubMed:21217699,
CC       ECO:0000269|PubMed:21691301, ECO:0000269|PubMed:22547026}.
CC   -!- INTERACTION:
CC       P02309:HHF2 (xeno); NbExp=2; IntAct=EBI-896414, EBI-8113;
CC       Q03164:KMT2A; NbExp=3; IntAct=EBI-896414, EBI-591370;
CC       Q99496:RNF2; NbExp=2; IntAct=EBI-896414, EBI-722416;
CC       P04637:TP53; NbExp=2; IntAct=EBI-896414, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10786633,
CC       ECO:0000269|PubMed:20018852}. Chromosome {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H7Z6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H7Z6-2; Sequence=VSP_014579;
CC         Note=Ref.4 (AAH37773) sequence is in conflict in position:
CC         454:I->M. {ECO:0000305};
CC   -!- PTM: Autoacetylation at Lys-274 is required for binding histone H4
CC       with high affinity and for proper function.
CC       {ECO:0000269|PubMed:22020126}.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL55762.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=AAL56648.1; Type=Frameshift; Positions=23, 26, 52; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK021872; BAB13924.1; -; mRNA.
DR   EMBL; AK024102; BAB14827.1; -; mRNA.
DR   EMBL; AK291106; BAF83795.1; -; mRNA.
DR   EMBL; AC009088; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135050; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471192; EAW52157.1; -; Genomic_DNA.
DR   EMBL; CH471192; EAW52158.1; -; Genomic_DNA.
DR   EMBL; BC037773; AAH37773.1; -; mRNA.
DR   EMBL; AF217501; AAL56648.1; ALT_FRAME; mRNA.
DR   EMBL; AF260665; AAF72665.2; -; mRNA.
DR   EMBL; AF289578; AAL55762.1; ALT_SEQ; mRNA.
DR   EMBL; AL050395; CAH56416.1; -; mRNA.
DR   CCDS; CCDS10706.1; -. [Q9H7Z6-1]
DR   CCDS; CCDS45468.1; -. [Q9H7Z6-2]
DR   RefSeq; NP_115564.2; NM_032188.2. [Q9H7Z6-1]
DR   RefSeq; NP_892003.2; NM_182958.2. [Q9H7Z6-2]
DR   UniGene; Hs.533803; -.
DR   PDB; 2GIV; X-ray; 1.94 A; A=174-449.
DR   PDB; 2PQ8; X-ray; 1.45 A; A=174-449.
DR   PDB; 2Y0M; X-ray; 2.70 A; A=174-458.
DR   PDB; 3QAH; X-ray; 2.10 A; A=174-449.
DR   PDB; 3TOA; X-ray; 3.00 A; A=177-458.
DR   PDB; 3TOB; X-ray; 2.70 A; A=177-458.
DR   PDB; 4DNC; X-ray; 2.05 A; A/B=170-458.
DR   PDB; 5J8C; X-ray; 2.17 A; A=177-458.
DR   PDB; 5J8F; X-ray; 2.60 A; A=177-458.
DR   PDBsum; 2GIV; -.
DR   PDBsum; 2PQ8; -.
DR   PDBsum; 2Y0M; -.
DR   PDBsum; 3QAH; -.
DR   PDBsum; 3TOA; -.
DR   PDBsum; 3TOB; -.
DR   PDBsum; 4DNC; -.
DR   PDBsum; 5J8C; -.
DR   PDBsum; 5J8F; -.
DR   ProteinModelPortal; Q9H7Z6; -.
DR   SMR; Q9H7Z6; -.
DR   BioGrid; 123914; 41.
DR   IntAct; Q9H7Z6; 13.
DR   MINT; MINT-1897597; -.
DR   STRING; 9606.ENSP00000406037; -.
DR   BindingDB; Q9H7Z6; -.
DR   ChEMBL; CHEMBL1932912; -.
DR   GuidetoPHARMACOLOGY; 2668; -.
DR   iPTMnet; Q9H7Z6; -.
DR   PhosphoSitePlus; Q9H7Z6; -.
DR   BioMuta; KAT8; -.
DR   DMDM; 68565938; -.
DR   EPD; Q9H7Z6; -.
DR   MaxQB; Q9H7Z6; -.
DR   PaxDb; Q9H7Z6; -.
DR   PeptideAtlas; Q9H7Z6; -.
DR   PRIDE; Q9H7Z6; -.
DR   Ensembl; ENST00000219797; ENSP00000219797; ENSG00000103510. [Q9H7Z6-1]
DR   Ensembl; ENST00000448516; ENSP00000406037; ENSG00000103510. [Q9H7Z6-2]
DR   Ensembl; ENST00000543774; ENSP00000456933; ENSG00000103510. [Q9H7Z6-1]
DR   GeneID; 84148; -.
DR   KEGG; hsa:84148; -.
DR   UCSC; uc002eax.4; human. [Q9H7Z6-1]
DR   CTD; 84148; -.
DR   DisGeNET; 84148; -.
DR   GeneCards; KAT8; -.
DR   HGNC; HGNC:17933; KAT8.
DR   HPA; HPA066324; -.
DR   MIM; 609912; gene.
DR   neXtProt; NX_Q9H7Z6; -.
DR   OpenTargets; ENSG00000103510; -.
DR   PharmGKB; PA38476; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   eggNOG; COG5027; LUCA.
DR   GeneTree; ENSGT00550000074503; -.
DR   HOVERGEN; HBG053268; -.
DR   InParanoid; Q9H7Z6; -.
DR   KO; K11308; -.
DR   OMA; MCLKWAP; -.
DR   OrthoDB; EOG091G0B73; -.
DR   PhylomeDB; Q9H7Z6; -.
DR   TreeFam; TF317619; -.
DR   BRENDA; 2.3.1.48; 2681.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   SIGNOR; Q9H7Z6; -.
DR   ChiTaRS; KAT8; human.
DR   EvolutionaryTrace; Q9H7Z6; -.
DR   GeneWiki; MYST1; -.
DR   GenomeRNAi; 84148; -.
DR   PRO; PR:Q9H7Z6; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103510; -.
DR   CleanEx; HS_MYST1; -.
DR   ExpressionAtlas; Q9H7Z6; baseline and differential.
DR   Genevisible; Q9H7Z6; HS.
DR   GO; GO:0000123; C:histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0000776; C:kinetochore; IEA:Ensembl.
DR   GO; GO:0071339; C:MLL1 complex; IDA:UniProtKB.
DR   GO; GO:0072487; C:MSL complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016407; F:acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035064; F:methylated histone binding; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IDA:UniProtKB.
DR   GO; GO:0016573; P:histone acetylation; IDA:UniProtKB.
DR   GO; GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB.
DR   GO; GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB.
DR   GO; GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB.
DR   GO; GO:0030099; P:myeloid cell differentiation; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0010506; P:regulation of autophagy; IDA:MGI.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR016197; Chromodomain-like.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR025995; Tudor-knot.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF11717; Tudor-knot; 1.
DR   SMART; SM00298; CHROMO; 1.
DR   SUPFAM; SSF54160; SSF54160; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Acyltransferase;
KW   Alternative splicing; Chromatin regulator; Chromosome;
KW   Complete proteome; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Transferase; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    458       Histone acetyltransferase KAT8.
FT                                /FTId=PRO_0000051566.
FT   DOMAIN       69    123       Chromo.
FT   DOMAIN      174    447       MYST-type HAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01063}.
FT   ZN_FING     207    232       C2HC MYST-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01063,
FT                                ECO:0000269|PubMed:22020126}.
FT   REGION      174    458       Sufficient for interaction with KANSL1.
FT   REGION      317    319       Acetyl-CoA binding.
FT                                {ECO:0000269|PubMed:21217699,
FT                                ECO:0000269|Ref.21}.
FT   REGION      324    330       Acetyl-CoA binding.
FT                                {ECO:0000269|PubMed:21217699,
FT                                ECO:0000269|Ref.21}.
FT   ACT_SITE    350    350       Proton donor/acceptor.
FT                                {ECO:0000303|PubMed:21217699,
FT                                ECO:0000303|PubMed:22020126,
FT                                ECO:0000305}.
FT   BINDING     354    354       Acetyl-CoA. {ECO:0000269|PubMed:21217699,
FT                                ECO:0000269|Ref.21}.
FT   BINDING     363    363       Acetyl-CoA. {ECO:0000269|PubMed:21217699,
FT                                ECO:0000269|Ref.21}.
FT   BINDING     432    432       Acetyl-CoA. {ECO:0000269|PubMed:21217699,
FT                                ECO:0000269|Ref.21}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5XI06}.
FT   MOD_RES      42     42       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5XI06}.
FT   MOD_RES     113    113       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     274    274       N6-acetyllysine; by autocatalysis.
FT                                {ECO:0000269|PubMed:21217699,
FT                                ECO:0000269|PubMed:21691301,
FT                                ECO:0000269|PubMed:22020126,
FT                                ECO:0000269|PubMed:22547026,
FT                                ECO:0000269|Ref.21}.
FT   MOD_RES     348    348       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     438    458       VDSVCLKWAPPKHKQVKLSKK -> GGWGAAVCRGRWGSVS
FT                                IWTGRSQGLLIAVT (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_014579.
FT   MUTAGEN     274    274       K->A: Abolishes histone acetyltransferase
FT                                activity. {ECO:0000269|PubMed:21217699}.
FT   MUTAGEN     274    274       K->R: Abolishes histone acetyltransferase
FT                                activity. {ECO:0000269|PubMed:22020126}.
FT   MUTAGEN     316    316       C->S: Strongly reduces histone
FT                                acetyltransferase activity.
FT                                {ECO:0000269|PubMed:21217699}.
FT   MUTAGEN     350    350       E->Q: Abolishes histone acetyltransferase
FT                                activity. {ECO:0000269|PubMed:21217699}.
FT   CONFLICT    222    222       S -> T (in Ref. 7; AAL55762).
FT                                {ECO:0000305}.
FT   CONFLICT    249    249       Y -> H (in Ref. 1; BAB14827).
FT                                {ECO:0000305}.
FT   CONFLICT    372    372       I -> N (in Ref. 1; BAB14827).
FT                                {ECO:0000305}.
FT   STRAND      181    184       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      187    190       {ECO:0000244|PDB:2PQ8}.
FT   HELIX       199    203       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      207    209       {ECO:0000244|PDB:2PQ8}.
FT   TURN        211    213       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      216    218       {ECO:0000244|PDB:2PQ8}.
FT   HELIX       220    229       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      236    243       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      246    252       {ECO:0000244|PDB:2PQ8}.
FT   TURN        253    255       {ECO:0000244|PDB:2PQ8}.
FT   HELIX       257    268       {ECO:0000244|PDB:2PQ8}.
FT   HELIX       274    277       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      283    292       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      295    305       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      312    315       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      317    319       {ECO:0000244|PDB:2PQ8}.
FT   HELIX       321    323       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      325    327       {ECO:0000244|PDB:2PQ8}.
FT   HELIX       328    342       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      347    349       {ECO:0000244|PDB:2PQ8}.
FT   HELIX       355    372       {ECO:0000244|PDB:2PQ8}.
FT   HELIX       383    389       {ECO:0000244|PDB:2PQ8}.
FT   HELIX       393    402       {ECO:0000244|PDB:2PQ8}.
FT   STRAND      406    409       {ECO:0000244|PDB:2GIV}.
FT   STRAND      412    415       {ECO:0000244|PDB:2GIV}.
FT   HELIX       419    427       {ECO:0000244|PDB:2PQ8}.
FT   TURN        429    431       {ECO:0000244|PDB:3QAH}.
FT   HELIX       440    442       {ECO:0000244|PDB:2PQ8}.
SQ   SEQUENCE   458 AA;  52403 MW;  66C474BE5B90E8E3 CRC64;
     MAAQGAAAAV AAGTSGVAGE GEPGPGENAA AEGTAPSPGR VSPPTPARGE PEVTVEIGET
     YLCRRPDSTW HSAEVIQSRV NDQEGREEFY VHYVGFNRRL DEWVDKNRLA LTKTVKDAVQ
     KNSEKYLSEL AEQPERKITR NQKRKHDEIN HVQKTYAEMD PTTAALEKEH EAITKVKYVD
     KIHIGNYEID AWYFSPFPED YGKQPKLWLC EYCLKYMKYE KSYRFHLGQC QWRQPPGKEI
     YRKSNISVYE VDGKDHKIYC QNLCLLAKLF LDHKTLYFDV EPFVFYILTE VDRQGAHIVG
     YFSKEKESPD GNNVACILTL PPYQRRGYGK FLIAFSYELS KLESTVGSPE KPLSDLGKLS
     YRSYWSWVLL EILRDFRGTL SIKDLSQMTS ITQNDIISTL QSLNMVKYWK GQHVICVTPK
     LVEEHLKSAQ YKKPPITVDS VCLKWAPPKH KQVKLSKK
//
